Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

3(50.0%)

Phase 2

1(16.7%)

Phase 3

1(16.7%)

Phase 1

1(16.7%)

6Total

N/A(3)

Phase 2(1)

Phase 3(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT05179733Phase 3Unknown

The Efficacy and Safety of ZR2 Versus R-miniCHOP in the Treatment of Unfit or Frail de Novo Diffuse Large B-cell Lymphoma Patients Aged Older Than or Equal to 70 Years

Role: collaborator

NCT02967913Not ApplicableCompleted

Urinary Symptoms and the Omission of the Bladder Flap at the Time of Primary Cesarean Delivery

Role: lead

NCT00204867Completed

Virtual Colonoscopy (VC) for Primary Colorectal Screening

Role: collaborator

NCT00079300Phase 1Completed

Imiquimod Cream in Treating Patients With Basal Cell Skin Cancer

Role: lead

NCT00733096Phase 2Completed

A 3-arm Multi-center, Randomized Controlled Study Comparing Transforaminal Corticosteroid, Transforaminal Etanercept and Transforaminal Saline for Lumbosacral Radiculopathy

Role: collaborator

NCT00925249Unknown

Comparison of the Tuberculin Skin Test (TST) and QuantiFERON ®-TB Gold Test (QFT-G) In Patients With Rheumatoid Arthritis Being Considered for Anti-TNF-Alpha Therapy

Role: collaborator

NCT00269503Not ApplicableTerminated

Chiropractic Prone Distraction for Lower Back Pain

Role: collaborator

NCT00623883Not ApplicableCompleted

Colonoscopic Removal of Aberrant Crypt Foci: a Prospective, Randomized, Blinded Trial

Role: lead

All 8 trials loaded